News
Peptide research news
Recent reporting from peer-reviewed journals, clinical trial readouts, and reputable outlets. Curated by Perplexity, sources cited.
news roundupDaily Peptide News & Research Updates
A peptide-focused news and analysis page covering regulatory updates, clinical trial results, longevity research, and industry developments.
news roundupNews | Peptidings
A peptide news and analysis page that tracks regulatory updates, clinical trial coverage, and evidence-based developments in the peptide space.
coverage_gapInsufficient search coverage to verify 15 recent peptide news items
The provided search results do not contain enough verifiable recent news coverage to compile 15 factual items about BPC-157, TB-500, ipamorelin, CJC-1295, MOTS-c, epitalon, selank, semax, melanotan, PT-141, AOD-9604, hexarelin, sermorelin, or tesamorelin from the last 90 days. The only result is a commercial lab services page mentioning BPC-157, which is not news coverage and does not satisfy the request for recent items.
Recent warning on research-grade peptides
CBS News reported on physician warnings against prescribing research-grade peptides sold online, emphasizing that many of these products are unapproved and untested. The segment highlighted growing concern about safety and misinformation around peptide use outside approved medical settings.
Health officials caution against unapproved peptide products
CBS News covered health officials' warnings that unapproved research-grade peptides promoted online are not FDA-approved and may be unsafe. The report focused on the risks of online sales and on efforts by officials to discourage prescribing these products.
data-qualityInsufficient search results to compile 15 verified recent peptide-news items
The provided search results are not news articles and do not cover the requested 90-day window, so I cannot reliably assemble 15 factual recent items with verified outlets, dates, and image URLs from the supplied material alone.
data-qualityPeptide catalog page is not a news source
This result is a product/catalog page for peptide compounds and does not provide recent journalism, preclinical study reporting, or regulatory coverage for the requested peptides.
1 in 7 peptide users buy from social media sellers
eMarketer reported survey data showing that a meaningful share of peptide users buy through social media sellers or other nontraditional sources. The piece highlights the commercial channels fueling peptide access, including online retailers, compounding pharmacies, and messaging apps.
orforglipronInvestigators to bring data on glucose management with oral orforglipron
A meeting preview says investigators will present data on glucose management with oral orforglipron, which FDA recently approved as the first small-molecule GLP-1 receptor agonist for weight loss, not type 2 diabetes.